Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients.
Joaquim
J
Bellmunt
D000230:Adenocarcinoma / Q000532:radiotherapy*; D000512:Alpha Particles / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000532:radiotherapy*; D006801:Humans; D007610:Kallikreins / Q000097:blood*; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000008:administration & dosage; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D011883:Radium / Q000008:administration & dosage*
D011868:Radioisotopes; D019275:Radiopharmaceuticals; C549870:KLK3 protein, human; D007610:Kallikreins; D017430:Prostate-Specific Antigen; C581106:radium Ra 223 dichloride; D011883:Radium